Health
NVAX Stock – Novavax vaccine effective vs COVID-19 variants – expert – Fintech Zoom
Stock analysis for Novavax Inc (NVAX:NASDAQ GS) including stock price, stock chart, company news, key statistics and fundamentals.
NVAX Stock – Novavax vaccine effective vs COVID-19 variants expert
Ghio Ong (The Philippine Star) – March 11, 2021 – 12:00am
MANILA, Philippines Theres a good chance that the COVID-19 vaccine developed by American drug firm Novavax could provide immunity against the other variants of the disease, a health expert revealed yesterday.
Speaking at the online Kapihan sa Manila Bay media forum, Dr. Luningning Villa, medical director of Faberco Life Sciences Inc., said Novavaxs Covovax has seen high efficacy…
-
Business14 hours agoWarning! These ASX 200 shares were just downgraded
-
General22 hours agoSergio Perez and Valtteri Bottas to return to Formula 1 with Cadillac
-
Business12 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General23 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts